Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.38 is 65% below its 5-year average of 3.99, near the low end of its 5-year range (1.29–20.09).
As of the fiscal period ended Tuesday, June 30, 2026. 40.49% below its 12-month average of 2.32.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.38.
CURRENT RATIO
1.38
CURRENT RATIO AVG TTM
2.32
CURRENT RATIO AVG 3Y
3.45
CURRENT RATIO AVG 5Y
3.99
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-40.49%
CURRENT VS 3Y AVG
-59.98%
CURRENT VS 5Y AVG
-65.40%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 798 covered companies
CURRENT VS SECTOR MEDIAN
-61.65%
vs the sector median at left
Sana Biotechnology, Inc.
Market Cap
$777.83M
Current Ratio
1.38
TTM Avg
2.32
3Y Avg
3.45
5Y Avg
3.99
Market Cap
$772.90M
Current Ratio
13.37
TTM Avg
5.16
3Y Avg
5.50
5Y Avg
4.90
Market Cap
$764.84M
Current Ratio
9.39
TTM Avg
11.79
3Y Avg
11.79
5Y Avg
11.79
Market Cap
$789.34M
Current Ratio
4.26
TTM Avg
4.46
3Y Avg
3.96
5Y Avg
4.08
Market Cap
$763.75M
Current Ratio
2.07
TTM Avg
1.18
3Y Avg
1.89
5Y Avg
3.24
Market Cap
$752.29M
Current Ratio
18.86
TTM Avg
23.23
3Y Avg
26.78
5Y Avg
32.61
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sana Biotechnology, Inc. (SANA) | $777.83M | 1.38 | 2.32 | 3.45 | 3.99 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | 13.37 | 5.16 | 5.50 | 4.90 |
| Apnimed, Inc. (APMD)vs › | $781.33M | N/A | N/A | N/A | N/A |
| Attovia Therapeutics, Inc. (ATTO)vs › | $764.84M | 9.39 | 11.79 | 11.79 | 11.79 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $789.34M | 4.26 | 4.46 | 3.96 | 4.08 |
| Mesa Laboratories, Inc. (MLAB)vs › | $763.75M | 2.07 | 1.18 | 1.89 | 3.24 |
| Geron Corporation (GERN)vs › | $789.07M | 6.92 | 5.11 | 3.93 | 4.38 |
| AdaptHealth Corp. (AHCO)vs › | $796.08M | 1.12 | 1.18 | 1.21 | 1.17 |
| Design Therapeutics, Inc. (DSGN)vs › | $752.29M | 18.86 | 23.23 | 26.78 | 32.61 |
| InMode Ltd. (INMD)vs › | $804.32M | 8.18 | 10.05 | 10.24 | 9.72 |
Current Ratio
1.38
Quick Ratio
1.38
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.38 |
| 2026-03-31 | 1.29 |
| 2025-12-31 | 1.89 |
| 2025-09-30 | 4.55 |
| 2025-06-30 | 2.47 |
| 2025-03-31 | 3.40 |
| 2024-12-31 | 3.54 |
| 2024-09-30 | 4.47 |
| 2024-06-30 | 5.20 |
| 2024-03-31 | 6.07 |
| 2023-12-31 | 3.31 |
| 2023-09-30 | 4.19 |
| 2023-06-30 | 3.02 |
| 2023-03-31 | 3.60 |
| 2022-12-31 | 3.99 |
| 2022-09-30 | 4.36 |
| 2022-06-30 | 5.09 |
| 2022-03-31 | 5.60 |
| 2021-12-31 | 5.62 |
| 2021-09-30 | 6.66 |
| 2021-06-30 | 20.09 |
| 2021-03-31 | 27.52 |
| 2020-12-31 | 12.22 |
| 2020-09-30 | 17.17 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 7.47 |
